Medeon Biodesign sells large bore vascular closure system to Terumo

Medeon Biodesign entered into a definitive asset purchase agreement with Terumo Corporation for its large bore vascular closure system (XPro System). The deal includes an upfront payment of US$20 million plus milestone payments.

“Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce today that it entered into a definitive asset purchase agreement with Tokyo-based Terumo Corporation (TSE: 4543) for its large bore vascular closure system.”en.prnasia.com

• 2 sources
• en.prnasia.comMedeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System - PR Newswire APACMar 5, 2018
• massdevice.comTerumo pays at least $20m for Medeon Biodesign's XPro vascular closure device - MassDeviceBrad PerrielloMar 5, 2018

Summarized from public sources; check the original articles before acting on it.